Skip to content
  • About
  • Shop
  • News
  • Contact Us
Search
NECA Logo
  • NET Nurse
  • Donate
  • What are NETs?
    • What are Neuroendocrine Cancers?
    • What are Pheos & Paras?
    • NET Symptoms
    • NET Types
    • Causes
    • Treatments
    • Grades
    • Diagnosis
    • Prognosis
    Consider the Grey Area
  • Patients & Carers
    • Patient & Carer Support
    • Patient Resources
    • Optimal Care Pathway
    • NET Nurse
    • Patient Stories
    • Share your Story
    • Australian NET Specialists
    • Clinical Trials
    • Living with NETS
    • Specialist Support Services
    Consider the Grey Area
  • Healthcare Professionals
    • Optimal Care Pathway
    • Professional Learning
    • Patient Referral
    • Clinical Trials
    • NET Symptoms
    • Australian NET Specialists
    • Request an In-Service
    • PLANET Registry
    • Order Booklets & Resources
    Consider the Grey Area
  • Get Involved
    • Advocate for Us
    • Share your Story
    • Donate
    • Fundraise
    • Events
    • In Memoriam
    • Corporate Partners
    • Gifts & Wills
    • Volunteer
    Senate MailChimp
  • NCD 2025
NET Nurse
Donate

Home » Advocacy » CommNETs 2024 Conference

CommNETs 2024 Conference

  • December 16, 2024

Specialists across the Commonwealth (Canada, New Zealand and Australia) shared the latest advancements in treatments, research, and patient support for those diagnosed with NETs. NeuroEndocrine Cancer Australia proudly presented an Australian update, ongoing clinical trials, government lobbying, education and key initiatives like the AUS-NET program and the PLANET registry, which play vital roles in improving outcomes for NET patients nationwide. Other presentations highlighted cutting-edge research in genomics and Theranostics.  CommNETs also provides the opportunity to have working groups to develop international guidelines, one of which is nutrition guidelines for NETs.

The Australian delegation (13 in total) included Meredith Cummins (NECA CEO), Erin Laing and Caley Schnaid (Dietitians), Dr. David Chan (Medical Oncologist and NECA Board Member), A/Prof Gabby Cehic AM (Nuclear Med Physician), A/Prof Grace Kong (Nuclear Med Physician) A/Prof David Wyld (Medical Oncologist) and Professor Michael Michael (Medical Oncologist). Together, they showcased Australia’s leadership in NET advocacy and care, underlining the importance of ensuring patients, regardless of their location, have access to the latest knowledge and support.

This global workshop provided a valuable opportunity to meet with peers from around the world, exchange ideas, and share experiences. The collaborative spirit highlights the power of working together as a diverse multidisciplinary team to  bridge gaps and improve outcomes in NET patient care. By sharing global expertise and taking proactive steps to reach patients Australia continues to deliver equitable, patient-centred optimal care.

Share this post

Recent posts

Rare Cancers Roundtable

September 26, 2025

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

September 26, 2025

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

September 20, 2025

Will Norman Nurse Webinar on Neuroendocrine Cancer

September 19, 2025
Categories
  • Advocacy
  • Awareness
  • Community Events
  • Education
  • Events
  • Fundraising
  • General
  • In The Media
  • News
  • Research
  • Unicorn Events
PrevPreviousNECA Christmas and New Year Closure Details
NextVale, Paul StephensonNext

Related Posts

Rare Cancers Roundtable

NECA recently attended a Rare Cancers Roundtable to discuss “The value of cancer clinical trials and setting up for success.” Attendees were diverse, including industry,

Shining a Light for World Neuroendocrine Cancer Day – Help Us Light Up Australia

Each year on 10 November for World Neuroendocrine Cancer Day, NeuroEndocrine Cancer Australia joins the global movement to raise awareness of Neuroendocrine Tumours (NETs). This

Will Norman Nurse Webinar on Neuroendocrine Cancer

On 17 September, NeuroEndocrine Cancer Australia, NeuroEndocrine UK, and NeuroEndocrine New Zealand came together to deliver the Will Norman Nurse Webinar on Neuroendocrine Cancer. Hosted

13th INCA Global NET Patient Advocate Summit

This week our CEO Meredith Cummins, in her role as President Elect of the INCA Board of Directors and Chair of the Research Committee, presented at

View All

Subscribe to Newsletter

NECA Logo
registered charity badge

What are NETs

  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies
  • About Us
  • Our People
  • Our Ambassadors
  • Consumer Advisory Group
  • International Advisory Panel
  • Governance & Policies

Patients & Carers

  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library
  • What are Neuroendocrine Cancers?​
  • Pheos and Paras
  • NET Library

Healthcare Professionals

  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials
  • Patient resources
  • NET Nurse
  • Patient Stories
  • Australian NET Specialists
  • Current Open Clinical Trials

Get Involved

  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
  • Shop
  • Donate
  • Volunteer
  • Current Fundraising Campaigns
  • Fundraise
All charity donations to NeuroEndocrine Cancer Australia may be tax-deductible in Australia.

Registered Charity CFN 202607
© 2025 NeuroEndocrine Cancer Australia
  • Website by Five Creative
Twitter Facebook Youtube Instagram Linkedin